Author:
Tupally Karnaker Reddy,Seal Prasenjit,Pandey Preeti,Lohman Rink‐Jan,Smith Sean,Ouyang Defang,Parekh Haredra
Reference195 articles.
1. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases
2. Challenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
3. COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies
4. Ashvattha Therapeutics Inc(2023).A Study to Evaluate the Safety Tolerability and Pharmacokinetics of D‐4517.2 After Subcutaneous Administration in Subjects With Neovascular (Wet) Age‐Related Macular Degeneration (AMD) or Subjects With Diabetic Macular Edema (DME) (Tejas).
5. Russia N.R.C.‐I.o.I.F.M.‐B.A.o. (2022)The siCoV/KK46 Drug Open‐safety Study.